Glen Eagle Advisors, LLC Bausch Health Companies Inc. Transaction History

Glen Eagle Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 13, 2024	SELL	$6.28 - $9.85 $885 - $1,388	-141 Closed	0 $0
Q3 2022 Aug 13, 2024	BUY	$4.58 - $9.21 $645 - $1,298	141 New	141 $971,000
Q3 2020 Aug 13, 2024	SELL	$14.88 - $20.13 $3,348 - $4,529	-225 Closed	0 $0
Q2 2020 Aug 13, 2024	BUY	$13.31 - $20.51 $2,994 - $4,614	225 New	225 $4.12 Million
Q4 2019 Aug 13, 2024	SELL	$18.89 - $31.89 $3,778 - $6,378	-200 Closed	0 $0
Q1 2019 Aug 13, 2024	BUY	$20.23 - $26.29 $4,046 - $5,258	200 New	200 $4.94 Million
Q3 2018 Aug 13, 2024	BUY	$20.64 - $25.67 $4,128 - $5,134	200 New	200 $5.13 Million

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.